🎁 Black Friday: up to 50% off of annual plans
Anthem Biosciences Limited (BOM:544449)
India flag India · Delayed Price · Currency is INR
950.95
+13.20 (1.41%)
At close: Nov 20, 2026

Anthem Biosciences Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Anthem Biosciences stock has a consensus rating of "Strong Buy" and an average price target of ₹1,015. The average 1-year stock price forecast is 6.75% higher than the current stock price, while the lowest is ₹900.00 (-5.36%) and the highest is ₹1,068 (+12.31%).

Price Target: ₹1,015 (+6.75%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹900.00₹1,015₹1,040₹1,068
Change-5.36%+6.75%+9.36%+12.31%

Analyst Ratings

The average analyst rating for Anthem Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy444555
Buy333333
Hold000000
Sell000000
Strong Sell000000
Total777888

Financial Forecast

Revenue This Year
25.37B
from 21.29B
Increased by 19.14%
Revenue Next Year
30.20B
from 25.37B
Increased by 19.06%
EPS This Year
13.82
from 10.74
Increased by 28.71%
EPS Next Year
15.99
from 13.82
Increased by 15.69%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027E
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
12.41B10.58B14.20B18.50B21.29B25.37B
Revenue Growth
12.24%-14.74%34.24%30.28%15.09%19.14%
Gross Profit
8.14B7.00B7.95B10.69B12.75B16.74B
Gross Margin
65.58%66.21%55.96%57.76%59.88%66.00%
Operating Income
5.20B3.72B4.25B5.88B7.08B8.92B
Net Income
4.06B3.85B3.67B4.51B5.92B7.58B
EPS
----10.7413.82
EPS Growth
-----28.71%
Forward PE
-----68.80
Dividend / Share
----2.002.00
Free Cash Flow
----6.37B595.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High28.4B
Avg25.4B
Low23.9B

Revenue Growth

Revenue Growth202720282029
High
33.4%
Avg
19.1%
Low
12.2%

EPS Forecast

EPS202720282029
High16.30
Avg13.82
Low12.88

EPS Growth

EPS Growth202720282029
High
51.8%
Avg
28.7%
Low
19.9%